» Articles » PMID: 18842695

ADRA2A Polymorphism and Smoking in a Turkish Population

Overview
Publisher Sage Publications
Date 2008 Oct 10
PMID 18842695
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Adrenoceptors (ARs) consist of nine subtypes, which are involved in a wide spectrum of physiological functions and are the site of action for a considerable percentage of currently prescribed therapeutics. All AR subtypes (except alpha(1D)) can be polymorphic because of the genetic variations in the coding and non-coding regions. Sixteen sequence variations were identified in alpha-adrenergic 2A (ADRA2A) gene. Among them, ADRA2A C1291G polymorphism is one of the most important polymorphisms, which plays a major role in regulating neurotransmitter release, blood pressure, lipolysis, insulin secretion, and platelet aggregation. A C-G transversion results in an MspI restriction fragment length polymorphism located at 1291 bp upstream of the origin of transcription. Because Medline search showed no study showing the allelic frequencies, and no information is available on inter-individual variability of ADRA2A C1291G polymorphism in Turkish population, we genotyped 203 healthy Turkish subjects. Because of large genetic variation of the polymorphism, we aimed to find out the distribution of C1291G polymorphism in Turkish population. Furthermore, we evaluated the possible association between the C1291G polymorphism in the ADRA2A receptor gene and smoking. The frequencies for the 1291C and 1291G alleles were 64% and 36%, respectively. The genotype frequencies for C1291C, C1291G, and G1291G were 35.5%, 57.6%, and 6.9%, respectively, in Turkish population. The allelic frequencies (1291C and 1291G) and G1291G homozygous variant genotype were similar to those reported in different Caucasian populations; however, C1291C and C1291G genotypes were different. We also observed that the frequency of the G allele was slightly higher in smoker subjects and lower among controls. The ADRA2A G allele may play a role in the predisposition to smoking. There is a need for expanding genotype and haplotype studies because of its importance in various physiological disorders and to confirm the association of this polymorphism with smoking.

Citing Articles

Pharmacodynamic Gene Testing in Prader-Willi Syndrome.

Forster J, Duis J, Butler M Front Genet. 2020; 11:579609.

PMID: 33329716 PMC: 7715001. DOI: 10.3389/fgene.2020.579609.


Interpatient variability in dexmedetomidine response: a survey of the literature.

Holliday S, Kane-Gill S, Empey P, Buckley M, Smithburger P ScientificWorldJournal. 2014; 2014:805013.

PMID: 24558330 PMC: 3914598. DOI: 10.1155/2014/805013.


Impact of COMT Val 108/158 Met and DRD2 Taq1B gene polymorphisms on vulnerability to cigarette smoking of Thai males.

Suriyaprom K, Tungtrongchitr R, Harnroongroj T J Mol Neurosci. 2012; 49(3):544-9.

PMID: 22740151 DOI: 10.1007/s12031-012-9844-z.


The role of the ADRA2A C1291G genetic polymorphism in response to dexmedetomidine on patients undergoing coronary artery surgery.

Yagar S, Yavas S, Karahalil B Mol Biol Rep. 2010; 38(5):3383-9.

PMID: 21104443 DOI: 10.1007/s11033-010-0446-y.